Use of colchicine in pregnancy: A systematic review and meta-analysis

Rheumatology (United Kingdom)

Volumn 57, Issue 2, 2018, Pages 382-387

  Indraratna, Praveen L ^a   Virk, Sohaib ^b   Gurram, Divya ^c   Day, Richard O ^a,d  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b Auburn Hospital   (Australia)

^c WESTMEAD HOSPITAL   (Australia)

^d ST VINCENT S HOSPITAL   (Australia)

Author keywords

Colchicine; Familial Mediterranean fever; Foetus; Malformation; Miscarriage; Pregnancy; Teratogenesis

Indexed keywords

COLCHICINE; ANTIRHEUMATIC AGENT;

ARTICLE; BIRTH WEIGHT; DRUG SAFETY; FAMILIAL MEDITERRANEAN FEVER; FETOTOXICITY; FETUS MALFORMATION; FETUS OUTCOME; GESTATIONAL AGE; HUMAN; INCIDENCE; META ANALYSIS; PREGNANCY; PREGNANT WOMAN; PREMATURITY; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; SPONTANEOUS ABORTION; SYSTEMATIC REVIEW; ADULT; CHEMICALLY INDUCED; DRUG INDUCED MALFORMATION; FEMALE; MATERNAL EXPOSURE; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; RHEUMATIC DISEASE;

ABNORMALITIES, DRUG-INDUCED; ABORTION, SPONTANEOUS; ADULT; ANTIRHEUMATIC AGENTS; BIRTH WEIGHT; COLCHICINE; FEMALE; GESTATIONAL AGE; HUMANS; MATERNAL EXPOSURE; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; RHEUMATIC DISEASES;

EID: 85041544973     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kex353     Document Type: Article

References (16)

1. Michael O, Goldman RD, Koren G. Safety of colchicine therapy during pregnancy. Can Fam Physician 2003;49: 967-9. PubMed PMID: 12943352
2. Shoji RMS. Preliminary notes on the teratogenic and embryocidal effects of colchicine on mouse embryos. Proc Jpn Acad 1966;42:822-7
3. Ferm V. Effect of transplacental mitotic inhibitors on the fetal hamster eye. Anat Rec 1964;148:129-37
4. Skoufias D, Wilson L. Mechanism of inhibition of microtubule polymerization by colchicine: inhibitory potencies of unliganded colchicine and tubulin-colchicine complexes. Biochemistry 1992;31:738-46
5. Smith M, Roberts D, Ritson S, Day R. Death and morbidity from supratherapeutic dosing of colchicine. Med J Aust 2011;194:612-3
6. Malawista S. The action of colchicine in acute gouty arthritis. Arthritis Rheum 1975;18:835-45
7. Australian Government, Department of Health, Therapeutic Goods Administration. Prescribing Medicines in Pregnancy Database 2016. https://www.tga.gov.au/prescribing-medicines-pregnancy-database (14 March 2017, date last accessed)
8. NPS MedicineWise. 2016. https://www.nps.org.au/medical-info/medicine-finder/colgout-tablets (14 March 2017, date last accessed)
9. Hozo S, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol 2005;5:13
10. Ben-Chetrit E, Ben-Chetrit A, Berkun Y, Ben-Chetrit E. Pregnancy outcomes in women with familial Mediterranean fever receiving colchicine: is amniocentesis justified? Arth Care Res 2010;62:143-8
11. Diav-Citrin O, Schectman S, Schwartz V et al. Pregnancy outcome after in utero exposure to colchicine. Am J Obstet Gynecol 2010;203:144.e1-6
12. Rabinovitch O, Zemer D, Kukia E, Sohar E, Maschiach S. Colchicine treatment in conception and pregnancy: two hundred thirty-one pregnancies in patients with familial Mediterranean fever. Am J Reprod Immunol 1992;28: 245-6
13. Yazicioglu A, Turgal M, Yucel O, Ozyuncu O, Beksac M. Pregnancy outcome in women with familial Mediterranean fever: A retrospective analysis of 50 cases with a 10-year experience. Arch Rheumatol 2014;29:94-8
14. Yasar O, Iskender C, Kaymak O et al. Retrospective evaluation of pregnancy outcomes in women with familial Mediterranean fever. J Matern Fetal Neonatal Med 2014;27:733-6
15. Mijatovic V, Hompes PG, Wouters MG. Familial Mediterranean fever and its implications for fertility and pregnancy. Eur J Obstet Gynecol Reprod Biol 2003;108:171-6. PubMed PMID: 12781406
16. Ofir D, Levy A, Wiznitzer A, Mazor M, Sheiner E. Familial Mediterranean fever during pregnancy: an independent risk factor for preterm delivery. Eur J Obstet Gynecol Reprod Biol 2008;141:115-8